Related Experiment Videos
[Thromboembolic complications in patients with prostheses].
Annales De Cardiologie Et D'Angeiologie
|December 1, 1985
Summary
Thrombo-embolic accidents (TEA) are a major complication of prosthetic heart valves, often causing neurological issues. Choosing the right prosthesis, considering factors like valve type and position, is key for prevention.
Area of Science:
- Cardiovascular Surgery
- Biomaterials Science
- Clinical Medicine
Context:
- Prosthetic heart valves are crucial for treating valvular heart disease.
- Thrombo-embolic accidents (TEA) are the primary complication associated with prosthetic valves.
- These events, particularly neurological, carry significant morbidity and mortality.
Purpose:
- To review the incidence, risk factors, and prevention strategies for thrombo-embolic accidents (TEA) in patients with prosthetic heart valves.
- To compare the thrombotic profiles of mechanical versus bioprosthetic valves.
- To evaluate the role of anticoagulant therapy and antiplatelet agents in TEA prevention.
Summary:
- Mechanical prosthetic valves, especially in the mitral position, are associated with a higher risk of TEA compared to bioprosthetic valves.
- Imperfect anticoagulant therapy with vitamin K antagonists (AVK) presents a significant bleeding risk, comparable to the thrombo-embolic risk.
- Recurrent embolisms occur in one-third of affected patients, highlighting the need for effective prevention.
Impact:
- Optimizing prosthetic valve selection based on individual patient factors can reduce TEA incidence.
- Understanding the risks associated with anticoagulant therapy is crucial for patient management.
- The findings support considering bioprosthetic valves more broadly to mitigate TEA risks in specific patient populations.